Proteomics

Dataset Information

0

HeLa cells were transfected with MARVELD1, then treated with or without HU treatment,following with IP and LC-MSMS analysis


ABSTRACT: To analyze MARVELD1 interacting proteins, HeLa cells were transfected with MARVELD1-Flag or pcDNA3.1 (PC), then treated with 8 mM Hydroxyurea (MCE, USA) or DMSO for 24 h, and subjected to IP assays with anti-DYKDDDDK magnetic agarose (Thermo, USA). After washing five times with PBS buffer, samples were boiled in 2× SDS loading buffer, resolved in SDS-PAGE, visualized by Coomassie Blue staining, and subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis (PTM Bio, China, project number: FA203GI).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Haoxiu Sun  

LAB HEAD: Haoxiu Sun

PROVIDER: PXD034445 | Pride | 2023-05-10

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
FA203GI_MD1_HU.raw Raw
FA203GI_MD1_ctrl.raw Raw
search.zip Other
Items per page:
1 - 3 of 3
altmetric image

Publications

The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells.

Sun Haoxiu H   Liu Chao C   Han Fang F   Lin Xiaoyu X   Cao Liangyu L   Liu Chenxing C   Ji Qiuyu Q   Cui Jinjin J   Yao Yuanfei Y   Wang Bojun B   Liao Yuanyu Y   Nie Huan H   Zhang Yanqiao Y   Li Yu Y  

Cell death and differentiation 20230207 4


The DNA damage response (DDR) plays crucial roles in cancer prevention and therapy. Poly(ADP-ribose) polymerase 1 (PARP1) mediates multiple signal transduction in the DDR as a master regulator. Uncovering the regulatory factors of PARP1 contributes to a more comprehensive view of tumorigenesis and treatment strategies. Here, we reveal that MARVELD1 acts as a mediator of DDR to perform early events and maintain genome stability. Mechanistically, PARP1 PARylates MARVELD1 at D102, D118 and D130, an  ...[more]

Similar Datasets

2019-02-25 | PXD012563 | Pride
2023-09-16 | PXD035903 | Pride
2018-03-09 | PXD008829 | Pride
2020-09-14 | PXD019239 | Pride
2024-06-17 | PXD050141 | Pride
2021-09-05 | GSE152862 | GEO
2019-02-02 | E-MTAB-4083 | biostudies-arrayexpress
2024-08-20 | PXD054722 | Pride
2024-10-25 | PXD040150 | Pride
2018-03-08 | GSE97020 | GEO